Novel strategies to prevent catheter-associated infections in oncology patients

Journal of Chemotherapy

Volumn 13, Issue SPEC. ISS. 1, 2001, Pages 239-250

  Schierholz, Jörg Michael ^a   Beuth, J ^a   Rump, A ^a   Konig D P ^a   Pulverer, G ^a  

^a CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

Author keywords

Catheter infection; Drug delivery; Infection prevention; Oncology

Indexed keywords

ANTIINFECTIVE AGENT; CYTOTOXIC AGENT; POLYMER;

BACTEREMIA; BACTERIUM CULTURE; BIOFILM; BLOOD CULTURE; CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANDIDA; CATHETER INFECTION; CONFERENCE PAPER; DEVICE REMOVAL; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TISSUE LEVEL; ENTEROCOCCUS; FUNGUS CULTURE; HOSPITAL COST; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INFECTION RISK; LENGTH OF STAY; MORBIDITY; MORTALITY; PREDICTION; QUANTITATIVE ASSAY; SEPTICEMIA; STAPHYLOCOCCUS; VIRULENCE;

EID: 0035720085     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.supplement-2.239     Document Type: Conference Paper

References (108)

1. Nosocomial infection rates in adult and paediatric intensive care units in the United States
2. Nosocomial bacteremia. A epidemiological overview
3. Pathogenesis, prevention, and management of infections due to intravascular devices used for infusion therapy
4. Risk factors for central venous catheter-related infections in surgical and intensive care units
5. Bacteraemia in surgical patients with intravenous devices: A European multicenter incidence study
6. Infections in surgery
7. Environmental bacteriology in the unidirectional (horizontal) operating room
8. Nosocomial bloodstream infections in the critically III
9. Intravenous access: Related problems in oncology
10. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial
11. Biomaterial-associated impairment of local neutrophil function
12. Characterization of a neutrophil-nhibitor factor from clinically significant S. epidermidis infection
13. MHC II: Expression is decreased in S. epidermidis graft infection
14. Prostaglandin E2 modulates monocyte MHC-II (Ia) suppression in biomaterial infection
15. Staphylococcus epidermidis graft infection is associated with locally suppressed major histocompatibility complex class II and elevated MAC-I expression
16. Pathogenesis of foreign body infections: Evidence for a local granulocyte defect
17. Decreased neutrophil respiratory burst on exposure to cobaltchrome alloy and polystyrene in vitro
18. Pathogenesis of foreign body infections: Description and characteristics of an animal model
19. Cell envelope proteins of S. epidermidis grown in vivo in a peritoneal chamber implant
20. Bacterial products primarily mediate fibroblast inhibition in biomaterial infection
21. Leukocyte-biomaterial interactions in the presence of Staphylococcus epidermidis: Flow cytometric evaluation of leukocyte activation
22. The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients
23. Immunosuppression augments growth of adherent Staphylococcus epidermidis
24. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory
25. Limitations of semiquantitative method for catheter culture
26. Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bacteremia?
27. Clinical predictors of infection of central venous catheters used for total parenteral nutrition
28. In situ management of confirmed central venous catheter-related bacteremia
29. Diagnosis of triple-lumen catheter infection: Comparison of roll plate, sonication, and flushing methodologies
30. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access
31. Long-term central venous access in oncology. Review of a caseload of 750 cases
32. Long-term follow-up of upper extremity implanted venous access devices in oncology patients
33. Novel antiinfective biomaterials by polymer modification
34. Bioactive polymers 61 synthesis and characterization of some retard antibiotics
35. Antibiotics immobilized on polysaccharides
36. Synthesis of N-(2-hydroxypropyl) methacrylamide copolymers with antimicrobial activity
37. The biocompatibility of silver
38. Treatment of orthopedic infections with electrically generated silver ions
39. Control of prosthetic bacterial infection: Evaluation of an easily incorporated, tightly bound, silver antibiotic PFTE graft
40. Activation of antibacterial silver coatings on surgical implants by direct current: Preliminary studies in rabbits
41. Newly made antibacterial braided nylon sutures. I. In vitro qualitative and in vivo preliminary biocompatibility study
42. Silver-nylon: A new antimicrobial agent
43. Inhibitory effects of electrically activated silver material on cutaneous wound bacteria
44. Antibacterial activity of actisorb plus, Actisorb and silver nitrate
45. Effect of silver oxide/trichloroisocyanuric acid antimicrobial urinary drainage system on catheter-associated bacteriuria
46. In vitro quantitative study of newly made antibacterial braided nylon sutures
47. Bacterial inhibition by electrical activation of percutaneous silver implants
48. New surface-treatment technologies for catheters used for extracorporeal detoxification methods
49. Scanning electron microscopic investigations of surface treated large-bore catheters used for extracorporeal detoxification methods
50. New processes for surface treatment of catheters
51. Silver alloy coated catheters reduce catheter-associated bacteriaemia
52. Antibacterial activity of multilayer silver-copper surface film on catheter material
53. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: A prospective randomized multicenter trial
54. A prospective randomized trial comparing the silver-impregnated collagen cuff with the bedside turned subclavian catheter
55. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, cottrolled trial
56. Failure of silver impregnated subcutaneous cuffs to prevent intravascular catheter infection
57. Subclavian haemodialysis catheter infections: A prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections
58. A large randomized clinical trial of a silver-impregnated urinary catheter: Lack of efficacy and staphylococcal superinfection
59. Silver coating of medical devices for catheter-associated infections?
60. Silver coating of medical devices - A review
61. Silver affects viability and structure of cultured mouse peritoneal macrophages and perioxidative capacity of whole mouse liver
62. An experimental study on silver in the nervous system and on aspects of its general cellular toxicity
63. Experimental argyrosis: Ultrastructural localization of silver in rat eye
64. Effects of selenium on toxicity and ultrastructural localization of silver in cultured macrophages
65. Muscle paralysis in a patient with total hip prosthesis and silver-impregnated antibacterial bone cement
66. In-vitro efficacy of a central venous catheter ("Hydrocath") loaded with teicoplanin to prevent bacterial colonization
67. In-vitro efficacy of a central venous catheter complexed with iodine to prevent bacterial colonization
68. A novel antimicrobial central venous catheter impregnated with benzalkonium chloride
69. Modification of central venous catheter polymers to prevent in vitro microbial colonisation
70. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial
71. Antibiotic bonded nephrostomy catheters for percutaneous nephrostomies
72. Failure of demonstrated clinical efficacy of antibiotic-bonded continuous ambulatory peritoneal dialysis (CAPD) catheters
73. Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters
74. Infection resistance of surface modified catheters with either short-lived or prolonged activity
75. Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients
76. Pharmacodynamics of antibiotics in fibrin clots
77. The enterococcus endocarditis model in experimental animals and its relevance to human infection
78. Pharmacokinetics of antibiotics in shallow and deep compartments
79. Sustained release of gentamicin from prosthetic heart valves
80. Experimental pathology of intravenous polyurethane cannulae containing disinfectant
81. Elution of disinfectant from polyurethane cannula tubing
82. The development of irgasan-impregnated intravenous cannulae
83. Antibiotic releasing polymers
84. Ciprofloxacin containing polyurethanes as potential drug delivery systems to prevent foreign-body infections
85. Efficacy of antibiotic-coated catheters in preventing subcutaneous staphylococcus aureus infection in rabbits
86. Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice
87. Drug release from antibiotic-containing polyurethanes
88. Controlled release of antibiotics from biomedical polyurethanes: Morphological and structural features
89. In vitro and in vivo efficacy of rifampin loaded silicone catheter in prevention of CSF-shunt infections
90. In vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection
91. Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination
92. Investigation of a rifampin, fusidic-acid and mupirocin releasing silicone catheter
93. Antibiotics and prevention of microbial colonization of catheters
94. Central venous catheters (CVC) coated with minocycline and rifampicin (m/r) for the prevention of catheter-related bacteremia (CRB)
95. Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers
96. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial
97. Decreasing catheter-related infection and hospital costs by continuous quality improvement
98. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters
99. The influence of triple-lumen central venous catheters coated with chlorhexidine/silver sulfadiazine on the incidence of catheter-related bacteraemia
100. Failure of antiseptic bonding to prevent central venous catheter related infection and sepsis
101. No difference in catheter sepsis between standard and antiseptic central venous catheters
102. High incidence of line-related infection and mechanical failure of an antiseptic impregnated central venous catheter in highly immunocompromised patients
103. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: A randomized controlled trial
104. Efficacy of antiseptic impregnated central venous catheters in preventing catheter-related bloodstream infections
105. Central venous catheters coated with miconazole and rifampin for the prevention of catheter-related colonization and bloodstream infections. Results of the pilot part of an ongoing clinical trial